I want to refer, Mr. Meulien, to your 2012-17 strategic plan from Genome. There was a section in there on innovation that included the argument that innovation is not always science-based and that research and innovation are distinct enterprises. The example used was that of Apple Corporation, which is recognized as one of the most innovative companies in the United States, despite being ranked 82nd in terms of research and development spending.
Why is it important for Genome Canada to emphasize the difference between research and innovation?